Skip to main content

Table 5 Quality of inpatient malaria case-management in Kano state, by admission ward

From: Health systems readiness and quality of inpatient malaria case-management in Kano State, Nigeria

 

Paediatric ward

(N = 891)

Medical ward

(N = 858)

All

patients

(N = 1,749)

n (%)

n (%)

n (%)

Composite test and treat performancea

127 (14.3)

104 (12.1)

231 (13.2)

Malaria test performed

442 (49.6)

376 (43.8)

818 (46.8)

Malaria test repeated

40 (9.1)

22 (5.9)

62 (7.6)

Treatment for test positive severe cases

N = 162

N = 120

N = 282

 Artesunate parenteral

97 (59.9)

71 (59.2)

168 (59.6)

 Artemether parenteral

36 (22.2)

29 (24.2)

65 (23.1)

 Arteether parenteral

4 (2.5)

6 (5.0)

10 (3.6)

 ACT

13 (8.0)

8 (6.7)

21 (7.5)

 Quinine parenteral

3 (1.9)

1 (0.8)

4 (0.2)

 Other anti-malarial treatmentsb

9 (5.6)

5 (4.2)

14 (5.0)

Treatment for test positive non-severe cases

N = 203

N = 135

N = 338

 ACT

10 (4.9)

5 (3.7)

15 (4.4)

 Artesunate parenteral

71 (35.0)

36 (26.7)

107 (31.7)

 Artemether parenteral

92 (45.3)

74 (54.8)

166 (49.1)

 Arteether parenteral

9 (4.4)

12 (8.9)

21 (6.2)

 Quinine parenteral

5 (2.5)

3 (2.2)

8 (2.4)

 Other anti-malarial treatmentsc

16 (7.9)

5 (3.7)

21 (6.2)

Treatment for test negative cases

N = 77

N = 121

N = 198

 No anti-malarial treatment

20 (26.0)

28 (23.1)

48 (24.2)

 Artesunate parenteral

16 (20.8)

19 (15.7)

35 (17.7)

 Artemether parenteral

26 (33.8)

60 (49.6)

86 (43.4)

 Arteether parenteral

3 (3.9)

6 (5.0)

9 (4.6)

 ACT

8 (10.4)

3 (2.5)

11 (5.6)

 Quinine parenteral

0

1 (0.8)

1 (0.5)

 Other anti-malarial treatmentsd

4 (5.2)

4 (3.3)

8 (4.5)

Treatment for not tested patients

N = 449

N = 482

N = 931

 No anti-malarial treatment

52 (11.6)

62 (12.9)

114 (12.2)

 Artesunate parenteral

159 (35.4)

81 (16.8)

240 (25.8)

 Artemether parenteral

171 (38.1)

246 (51.0)

417 (44.8)

 Arteether parenteral

15 (3.3)

19 (3.9)

34 (3.7)

 ACT

31 (6.9)

49 (10.2)

80 (8.6)

 Quinine parenteral

3 (0.7)

4 (0.8)

7 (0.8)

 Other anti-malarial treatmentse

18 (4.0)

21 (4.4)

39 (4.2)

  1. aPerformance of malaria test and either artesunate treatment for test positive severe cases, ACT for test positive non-severe cases or no anti-malarial treatment for test negative cases
  2. bInclude 11 AS/artemether, 1 arteether/artemether, 1 AS/quinine and 1 AS/arteether treatment
  3. cInclude 11 AS/artemether, 3 arteether/artemether, 2 AS/quinine, 2 artemether/quinine, 1 arteether/quinine, 1 AS/arteether and 1 SP treatment
  4. dInclude 4 AS/artemether and 4 arteether/artemether treatment
  5. eInclude 15 AS/artemether, 13 arteether/artemether, 3 AS/arteether, 3 SP, 1 quinine/artemether, 1 AS/quinine, 1 artemether syrup, 1 ACT/SP and 1 quinine/artemether/arteether treatment